Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Paolo Hitz"'
Autor:
Jessica Bassi, Olivier Giannini, Chiara Silacci-Fregni, Laura Pertusini, Paolo Hitz, Tatiana Terrot, Yves Franzosi, Francesco Muoio, Christian Saliba, Marcel Meury, Exequiel A Dellota, Josh R Dillen, Patrick Hernandez, Nadine Czudnochowski, Elisabetta Cameroni, Nicola Beria, Mariangela Ventresca, Alberto Badellino, Soraya Lavorato-Hadjeres, Elisabetta Lecchi, Tecla Bonora, Matteo Mattiolo, Guido Trinci, Daniela Garzoni, Giuseppe Bonforte, Valentina Forni-Ogna, Davide Giunzioni, Lorenzo Berwert, Ravindra K Gupta, Paolo Ferrari, Alessandro Ceschi, Pietro Cippà, Davide Corti, Antonio Lanzavecchia, Luca Piccoli
Publikováno v:
PLoS ONE, Vol 17, Iss 2, p e0263328 (2022)
Patients on dialysis are at risk of severe course of SARS-CoV-2 infection. Understanding the neutralizing activity and coverage of SARS-CoV-2 variants of vaccine-elicited antibodies is required to guide prophylactic and therapeutic COVID-19 intervent
Externí odkaz:
https://doaj.org/article/4ce2664a869c4d07a5a6ccbca6a84ad8
Autor:
Elisabetta Lecchi, Josh Dillen, Paolo Ferrari, Chiara Silacci-Fregni, Nadine Czudnochowski, Marcel Meury, Tecla Bonora, Valentina Forni-Ogna, Jessica Bassi, Exequiel Dellota, Matteo Mattiolo, Guido Trinci, Laura Pertusini, Christian Saliba, Yves Franzosi, Pietro E. Cippà, Ravindra K. Gupta, Antonio Lanzavecchia, Tatiana Terrot, Giuseppe Bonforte, Olivier Giannini, Mariangela Ventresca, Luca Piccoli, Alberto Badellino, Soraya Lavorato-Hadjeres, Nicola Beria, Davide Corti, Daniela Garzoni, Paolo Hitz, Alessandro Ceschi, Davide Giunzioni, Elisabetta Cameroni, Francesco Muoio, Lorenzo Berwert, Patrick Hernandez
Publikováno v:
PLoS ONE, Vol 17, Iss 2, p e0263328 (2022)
Funder: Swiss Kidney Foundation
Patients on dialysis are at risk of severe course of SARS-CoV-2 infection. Understanding the neutralizing activity and coverage of SARS-CoV-2 variants of vaccine-elicited antibodies is required to guide prophylact
Patients on dialysis are at risk of severe course of SARS-CoV-2 infection. Understanding the neutralizing activity and coverage of SARS-CoV-2 variants of vaccine-elicited antibodies is required to guide prophylact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec829b2d810c73e81db5599f6bc5d084
https://doi.org/10.1371/journal.pone.0263328
https://doi.org/10.1371/journal.pone.0263328